The Emergence of Azithromycin-resistant Typhi in Nepal

Overview

Journal JAC Antimicrob Resist

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2021 Jul 5

PMID 34223059

Citations 24

Authors

Pham Thanh Duy

Sabina Dongol

Abhishek Giri

Nguyen Thi Nguyen To

Ho Ngoc Dan Thanh

Nguyen Pham Nhu Quynh

Pham Duc Trung

Guy E Thwaites

Buddha Basnyat

Stephen Baker

Maia A Rabaa

Abhilasha Karkey

Affiliations

Soon will be listed here.

Abstract

Background: Typhoid fever remains a significant cause of morbidity and mortality in Asia and Africa. The emergence of azithromycin resistance in South Asia is concerning, as azithromycin is one of the last effective oral drugs for treating typhoid.

Objectives: To describe the molecular mechanism and phylogenetics of azithromycin-resistant (Azith) Typhi isolates from Patan Hospital, Kathmandu, Nepal.

Methods: Whole-genome sequences of three Azith . Typhi isolates (MIC >256 mg/L) were analysed and compared with a global collection to investigate the azithromycin resistance mechanism and phylogenetic structure. Clinical information is reported for one of the three patients infected with Azith . Typhi.

Results: The three Azith isolates belonged to the H58 lineage and were genetically identical; they were distantly related to contemporaneous . Typhi from Nepal and Azith . Typhi recently described in Bangladesh. Azithromycin resistance was mediated by a non-synonymous mutation in the gene (R717L). The three Azith isolates showed reduced susceptibility to ciprofloxacin (double mutation in the : S83F and D87G), and were susceptible to ampicillin, chloramphenicol and co-trimoxazole. Clinical information from one patient suggested non-response to azithromycin treatment.

Conclusions: This is the first molecular description of Azith . Typhi in Nepal. These organisms showed no phylogenetic link to Azith . Typhi in Bangladesh. Our data suggest that increasing use of azithromycin may pose a strong selective pressure driving the emergence of Azith . Typhi in South Asia. Further investigations are needed to evaluate treatment responses to azithromycin, predict evolutionary trajectories, and track the transmission of these organisms.

Citing Articles

Plasma concentration of azithromycin and correlation with clinical outcomes in patients with enteric fever.

Bandyopadhyay R, Mathew S, Veeraraghavan B, Samuel P, Backiyaraj J, Sathyendra S JAC Antimicrob Resist. 2025; 7(1):dlaf015.

PMID: 39973907 PMC: 11836883. DOI: 10.1093/jacamr/dlaf015.

Azithromycin-resistant mph(A)-positive Salmonella enterica serovar Typhi in the United States.

Tagg K, Kim J, Henderson B, Birhane M, Snyder C, Boutwell C J Glob Antimicrob Resist. 2024; 39:69-72.

PMID: 39173740 PMC: 11663695. DOI: 10.1016/j.jgar.2024.08.005.

The origins of haplotype 58 (H58) Salmonella enterica serovar Typhi.

Carey M, Thi Nguyen T, Nhu Tran D, Dyson Z, Keane J, Thanh D Commun Biol. 2024; 7(1):775.

PMID: 38942806 PMC: 11213900. DOI: 10.1038/s42003-024-06451-8.

Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.

Lancet Glob Health. 2024; 12(3):e406-e418.

PMID: 38365414 PMC: 10882211. DOI: 10.1016/S2214-109X(23)00585-5.

Typhoid fever.

Meiring J, Khanam F, Basnyat B, Charles R, Crump J, Debellut F Nat Rev Dis Primers. 2023; 9(1):71.

PMID: 38097589 DOI: 10.1038/s41572-023-00480-z.

References

Wain J, Hendriksen R, Mikoleit M, Keddy K, Ochiai R . Typhoid fever. Lancet. 2014; 385(9973):1136-45. PMC: 11567078. DOI: 10.1016/S0140-6736(13)62708-7. View

Gupta S, Padmanabhan B, Diene S, Lopez-Rojas R, Kempf M, Landraud L . ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother. 2013; 58(1):212-20. PMC: 3910750. DOI: 10.1128/AAC.01310-13. View

Inouye M, Dashnow H, Raven L, Schultz M, Pope B, Tomita T . SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med. 2014; 6(11):90. PMC: 4237778. DOI: 10.1186/s13073-014-0090-6. View

Klemm E, Shakoor S, Page A, Qamar F, Judge K, Saeed D . Emergence of an Extensively Drug-Resistant Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins. mBio. 2018; 9(1). PMC: 5821095. DOI: 10.1128/mBio.00105-18. View

Stamatakis A . RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014; 30(9):1312-3. PMC: 3998144. DOI: 10.1093/bioinformatics/btu033. View

Andrews J, Qamar F, Charles R, Ryan E . Extensively Drug-Resistant Typhoid - Are Conjugate Vaccines Arriving Just in Time?. N Engl J Med. 2018; 379(16):1493-1495. DOI: 10.1056/NEJMp1803926. View

Britto C, Dyson Z, Duchene S, Carter M, Gurung M, Kelly D . Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy. PLoS Negl Trop Dis. 2018; 12(4):e0006408. PMC: 5933809. DOI: 10.1371/journal.pntd.0006408. View

Letunic I, Bork P . Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2006; 23(1):127-8. DOI: 10.1093/bioinformatics/btl529. View

Carattoli A, Zankari E, Garcia-Fernandez A, Larsen M, Lund O, Villa L . In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014; 58(7):3895-903. PMC: 4068535. DOI: 10.1128/AAC.02412-14. View

10.

Zellweger R, Basnyat B, Shrestha P, Prajapati K, Dongol S, Sharma P . Changing Antimicrobial Resistance Trends in Kathmandu, Nepal: A 23-Year Retrospective Analysis of Bacteraemia. Front Med (Lausanne). 2018; 5:262. PMC: 6156253. DOI: 10.3389/fmed.2018.00262. View

11.

Parry C, Tran Vu Thieu N, Dolecek C, Karkey A, Gupta R, Turner P . Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. Antimicrob Agents Chemother. 2015; 59(5):2756-64. PMC: 4394775. DOI: 10.1128/AAC.04729-14. View

12.

Effa E, Bukirwa H . Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2008; (4):CD006083. DOI: 10.1002/14651858.CD006083.pub2. View

13.

Tanmoy A, Westeel E, De Bruyne K, Goris J, Rajoharison A, Sajib M . Serovar Typhi in Bangladesh: Exploration of Genomic Diversity and Antimicrobial Resistance. mBio. 2018; 9(6). PMC: 6234861. DOI: 10.1128/mBio.02112-18. View

14.

Park S, Pham D, Boinett C, Wong V, Pak G, Panzner U . The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa. Nat Commun. 2018; 9(1):5094. PMC: 6269545. DOI: 10.1038/s41467-018-07370-z. View

15.

Pascual A, Conejo M, Garcia I, Perea E . Factors affecting the intracellular accumulation and activity of azithromycin. J Antimicrob Chemother. 1995; 35(1):85-93. DOI: 10.1093/jac/35.1.85. View

16.

Wong V, Baker S, Pickard D, Parkhill J, Page A, Feasey N . Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events. Nat Genet. 2015; 47(6):632-9. PMC: 4921243. DOI: 10.1038/ng.3281. View

17.

Hooda Y, Sajib M, Rahman H, Luby S, Bondy-Denomy J, Santosham M . Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance. PLoS Negl Trop Dis. 2019; 13(11):e0007868. PMC: 6881056. DOI: 10.1371/journal.pntd.0007868. View

18.

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N . The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. PMC: 2723002. DOI: 10.1093/bioinformatics/btp352. View

19.

Wong V, Baker S, Connor T, Pickard D, Page A, Dave J . An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid. Nat Commun. 2016; 7:12827. PMC: 5059462. DOI: 10.1038/ncomms12827. View